Dear Editor, Cutaneous leishmaniasis is caused by a flagellated parasite and transmitted through a bite by bloodsucking sand-flies. [1] Cutaneous leishmaniasis is characterized by ulcerative skin lesions. This is an endemic disease in the Middle East, especially Iran, Afghanistan, Pakistan, Bangladesh, Indian, and Nepal. [2] Since the 1940s, pentavalent antimony compounds have been considered as the first line of treatment for all forms of leishmaniasis. Meglumine antimoniate and sodium stibogluconate are the well-known pentavalent antimony agents. [3] Glucantime (Sanofi Aventis, France) is a brand product of meglumine antimoniate, which is supplied in 5 mL colorless ampules with concentration 300 mg/mL. Every five ampules are packed in a box, and there are not any visible particles in Glucantime ampules. In January 2019, a batch of meglumine antimoniate under brand "Gulucatime" is imported to Iran and is distributed between certain health centers. The appearance of this product was the same as pervious "Glucantime" bathes, except the obvious typographical error [ Figure 1 ]. Visible sediment particles in some ampules and improper packaging also were remarkable [ Figure 2 ]. Iranian dermatologists prescribed "Gulucatime" for cutaneous leishmaniasis patients in the mentioned period. However, the clinical outcome was not seen at all, and the clinical situation of patients deteriorated. After a while, the physician suspected of the originality of the "Gulucatime" and similar reports was seen in Pakistan. Finally, the WHO Region of the Eastern Mediterranean confirmed counterfeit meglumine antimoniate (Gulucatime) circulating in Iran and Pakistan. [4] Counterfeit drugs, especially lifesaving drugs, target the health of patients in less developed countries. It is necessary to make stronger state licensure supervision to avoid such disasters. [5] This letter emphasis to aware the physicians regarding counterfeit meglumine antimoniate. The physician should avoid prescribing such medicines if there is any abnormal sign in medicine package, including typographical errors and sediment particles.
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Emphasizing the Role of Pharmacist as a Researcher: The Lebanese Order of Pharmacists' Perspective
Dear Editor, Pharmacy is an ever-changing profession all over the world. In 1997, the World Health Organization introduced the "Seven-star pharmacist" concept covering the different roles each pharmacist must perform: caregiver, decision-maker, communicator, manager, life-long-learner, teacher, and leader. [1] Two additional roles (researcher and entrepreneur) were introduced later, leading to the "Nine-star pharmacist," [2] thus emphasizing the importance of research within professional practice and academia.
While it is not expected that all pharmacists conduct research projects, it is vital that pharmacists who are not interested in research would yet understand research concepts, the general process, and be able to assess the validity and credibility of research conducted by others. Having such knowledge will enable the researcher to successfully include research data and conclusions into useful reports/documents. However, the researcher-pharmacist wishing to conduct field research will need a much higher level of understanding in this discipline, which makes graduate studies an exciting option.
In Lebanon, the vast majority of pharmacists have a Bachelor of Sciences (BS Pharm) or a Doctor of Pharmacy (PharmD) degree, while very few have a master degree, and even fewer have a PhD. Despite a potentially high demand for specialized pharmacists, a small number of researchers with much-needed skills graduate yearly. While some faculties of pharmacy in Lebanon offer master and PhD degrees to meet this growing need, [3] the field does not seem to be appealing for pharmacy graduates, and it is estimated that around 15 pharmacists pursue a PhD out of 450 graduates (3.33%) annually. There are various reasons why most pharmacists choose not to advance their education (or move forward with their education). First, the Ministry of Public health does not recognize research degrees as a specialty, the majority of available positions for pharmacists are in fields where research-related skills are not required while pharmacists have no clear idea about the scope of research degrees and its importance in any area of practice.
Moreover, there are very few research positions in specialized research centers in Lebanon. Even in academia where research should be most valued, recruitment, promotion, and remuneration of pharmacists take into account teaching and service components rather than research activity in the majority of Lebanese universities. Furthermore, budget constraints and subsequently, the quality of publishable papers might hinder the submission for publication in high-impact peer-reviewed journals (7).
In view of what was said, a competency framework for pharmacists was identified as a critical requirement in the development of undergraduate and postgraduate education for pharmacists in Lebanon. Hence, the Lebanese Order of Pharmacists (OPL, the official pharmacy association in Lebanon) developed the core competency framework for pharmacists that comprised the minimal competencies required for several pharmacy specialties, including those of a researcher-pharmacist.
For
all research pharmacists, competencies encompassed one major core axis, the soft skills. This axis is focused on five major domains: (1) critical thinking/scientific inquisitiveness/ethical thinking, and research conduct/strategic thinking; (2) oral and written
